Cannabinoid receptor type 2 (CB2) modulators and uses thereof
AssigneeTeon Therapeutics, Inc.
InventorsElfatih Elzein, Jiwen Liu
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compounds, compositions, and methods for modulating the Cannabinoid receptor 2 (CB2) with the compounds and compositions disclosed herein. Also described are methods of treating diseases or conditions that are mediated by the action of Cannabinoid receptor 2 (CB2) or that we benefit from modulating the Cannabinoid receptor 2 (CB2).
Claims9
A method for treating bladder cancer, colon cancer, brain cancer, breast cancer, endometrial cancer, heart cancer, kidney cancer, lung cancer, liver cancer, uterine cancer, blood and lymphatic cancer, ovarian cancer, pancreatic cancer, prostate cancer, thyroid cancer, or skin cancer in a mammal in need thereof, the method comprising administering to the mammal a compound selected from:
- 8
- 12
- 13
- 46
- 54
- 59
- 83
- 110
- 115
- 116
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 165
- 166
- 173
- 177
- 180
- or a pharmaceutically acceptable salt or stereoisomer thereof.
Dependencies are inferred from the claim text.